Titolo	Data di pubblicazione	Autore(i)
1	Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells	2012	I. Campia; J. Kopecka; B. Castella; M. Rigoni; M. Coscia; A. Bosia; D. Ghigo; M. Massaia; C. Riganti
2	Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells	2013	C. Riganti; B. Castella; J. Kopecka; I. Campia; M. Coscia; G. Pescarmona; A. Bosia; D. Ghigo; M. Massaia
3	Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway	2010	Coscia M; Quaglino E; Iezzi M; Curcio C; Pantaleoni F; Riganti C; Holen I; Mönkkönen H; Boccadoro M; Forni G; Musiani P; Bosia A; Cavallo F; Massaia M
4	THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT	2009	Coscia M; Pantaleoni F; Riganti C; Rigoni M; Vitale C; Peola S; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M.
5	The pentose phoshate pathway plays an essential role in supporting human sperm capacitation	2010	Miraglia E; Lussiana C; Viarisio D; Racca C; Cipriani A; Gazzano E; Bosia A; Revelli A; Ghigo D
6	The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress	2008	RIGANTI C; COSTAMAGNA C; DOUBLIER S; MIRAGLIA E; POLIMENI M; BOSIA A; GHIGO D
7	The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress	2006	RIGANTI C; COSTAMAGNA C; BOSIA A; GHIGO D
8	[The molecular basis for increased rigidity of the erythrocyte membrane]	1983	PESCARMONA GP ;GHIGO D ;BOSIA A
9	The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL)	2012	Micol Rigoni; Marta Coscia; Chiara Riganti; Ivana Campia; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
10	The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells	2011	Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Valentina Griggio; Silvia Peola; Barbara Castella; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
11	The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL)	2012	Marta Coscia; Micol Rigoni; Chiara Riganti; Candida Vitale; Ivana Campia; Valentina Griggio; Myriam Foglietta; Barbara Castella; Patrizia Sciancalepore; Maria Elisa Canepari; Marta Robino; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
12	The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL)	2008	M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia
13	THE LOCAL MICROENVIRONMENT PLAYS A DIFFERENT ROLE IN THE SURVIVAL OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED AND UNMUTATED IMMUNOGLOBULIN (IG) VH GENES	2009	M. Coscia;1 F. Pantaleoni; C. Riganti; M. Rigoni; S. Peola; C. Vitale; D. Drandi; M. Ladetto; A. Bosia; M. Boccadoro; M. Massaia
14	The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL	2009	Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G
15	The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status.	2010	Marta Coscia; Candida Vitale; Silvia Peola; Chiara Riganti; Daniela Angelini; Myriam Foglietta; Francesca Pantaleoni; Giorgia Matta; Sabina Chiaretti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Luca Battistini; Robin Foà; Mario Boccadoro; Jean-Jacques Fournié; Massimo Massaia
16	The concentration of nitrite in seminal plasma does not correlate with sperm concentration, sperm motility, leukocytospermia and sperm culture.	2001	A. REVELLI; L. BERGANDI; M. MASSOBRIO; B. LINDBLOM; A. BOSIA; D. GHIGO
17	The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases the in vitro drug delivery across blood-brain barrier cells.	2012	Pinzón-Daza ML; Garzón R; Couraud PO; Romero IA; Weksler B; Ghigo D; Bosia A; Riganti C
18	Temozolomide epigenetically down-regulates Wnt3a-dependent signaling and P- glycoprotein in glioblastoma stem cells	2012	I. Campia; I.C. Salaroglio; J. Kopecka; M.L. Pinzòn; V. Caldera; D. Ghigo; A. Bosia; D. Schiffer; C. Riganti
19	Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3-signalling.	2014	C. Riganti; IC. Salaroglio; ML Pinzòn-Daza; V. Caldera; I. Campia; J. Kopecka; M. Mellai; L. Annovazzi; PO. Couraud; A. Bosia; D. Ghigo; D. Schiffer
20	Temozolomide down-regulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/GSK3/β-catenin pathway	2013	C. Riganti; IC. Salaroglio; V. Caldera; I. Campia; J. Kopecka; M. Mellai; L. Annovazzi; A. Bosia; D. Ghigo; D. Schiffer